Maykin Ho Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Maykin Ho.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Maykin Ho. Maykin Ho is a Director in PAREXEL INTERNATIONAL CORP ($PRXL) and a Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a Director in FIBROGEN INC ($FGEN) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO).
Address: C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Maykin Ho is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maykin Ho: Director
Holdings: 3,278 shares
Current Value: $145,609
Latest Transaction: Jun 01 2020
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maykin Ho: Director
Holdings: 2,350 shares
Current Value: $208,939
Latest Transaction: Feb 19 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIBROGEN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Maykin Ho: Director
Holdings: 11,255 shares
Current Value: $268,995
Latest Transaction: Jun 08 2020
$FGEN Market Capitalization: $1.47B
$FGEN Previous Close: $23.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PAREXEL INTERNATIONAL CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Maykin Ho: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 04 2017
$PRXL Market Capitalization: $3.40B
$PRXL Previous Close: $62.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Maykin Ho
Sentiment: All, AGIO, BMRN, FGEN, PRXL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ho Maykin | Director | Grant | A | 0.00 | 2,350 | 0 | 2,350 | 0 to 2.4 K |
| Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
| Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Grant | A | 0.00 | 4,700 | 0 | 11,255 | 6.6 K to 11.3 K (+71.70 %) |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Buy | M | 0.00 | 1,878 | 0 | 3,278 | 1.4 K to 3.3 K (+134.14 %) |